indications for tirzepatide Weight Loss Who Qualifies for Tirzepatide Medical

Do not be one of those people

Indeed, CDER Acting Director Michael Davis reinforced the policy point publicly on X, emphasizing that compounded GLP1 products are not FDAapproved and have not undergone the rigorous review for safety, efficacy, and manufacturing quality that is required for drugs approved through the new drug application (NDA) or abbreviated new drug application (ANDA) pathways.[3] This is now the third major set of warning letters in less than a year with the majority aimed at telehealth marketing of compounded GLP-1 products: September 2025: roughly 80 warning letters and 40 untitled letters March 2026: 30 warning letters June 2026: 25 warning letters The Claims FDA Is Targeting As in earlier rounds, the June 2026 letters appear highly standardized and focus on consumerfacing promotion of compounded GLP-1 products

References Further Reading All Spleen Content Splenectomy (Spleen Removal) Enlarged Spleen (Splenomegaly) Causes of Spleen Pain How is an Enlarged Spleen Diagnosed

GraphPad Prism software was used for drawing figures